Last updated: June 5, 2026

Back to directory

Us2.ai medical AI product profile

FDA-cleared AI echocardiography platform that automates measurements, disease-detection support, and structured reporting from DICOM echo studies.

Screenshot of the official Us2.ai product page
Medical imaging and radiology

Best fit

Echo labs and cardiology programs that need reproducible measurement automation and structured reporting while preserving cardiologist interpretation.

Primary use case
Automated transthoracic echocardiography analysis, measurement extraction, disease-detection support, and structured echo reporting
Audience
Cardiology teams, echocardiography labs, health systems, outpatient imaging centers, and enterprise ultrasound programs
Risk level
High
Pricing signal
Enterprise and provider pricing; request current module, deployment, regional availability, and integration terms.
Official sources
6 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Us2.ai as safe for a local clinical, operational, or research workflow.

Regulatory / FDAMatch the exact Us2.ai version, intended use, automated parameter set, disease-detection output, geography, and market authorization before using results in clinical echo reporting.
PrivacyReview DICOM routing, cloud versus on-premises deployment, regional data residency, PACS/CVIS/report delivery, subprocessors, BAA or data-processing terms, access controls, and support-data handling.
EvidenceValidate automated measurements and disease-detection outputs against local echo-lab readers, scanner mix, patient population, image quality, false-alert burden, and downstream clinical decisions.
WorkflowBest governed as cardiologist-reviewed echo automation that feeds structured reporting and quality-control workflows, with explicit rules for failed studies, overrides, and post-deployment monitoring.

Where Us2.ai fits

Us2.ai describes an FDA-cleared automated echocardiography platform for DICOM-based measurements, disease-detection support, and structured reports; product, regulatory, integration, and security materials describe multi-market clearances, PACS/CVIS/reporting integration, regional data residency or on-premises deployment options, and enterprise compliance claims.

Not for: Standalone cardiovascular diagnosis, unsupported ultrasound studies, unsupported geographies, or deployment without cardiology review and quality monitoring.

What to verify before using Us2.ai

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products